MiR‐335‐5p restores cisplatin sensitivity in ovarian cancer cells through targeting BCL2L2
Abstract Objective Our study was designed to explore the association miR‐335‐5p and BCL2L2 and to investigate the influence of miR‐335‐5p/BCL2L2 axis on cisplatin‐resistant ovarian cancer cells. Methods Microarray analysis was used to determine differentially expressed microRNAs in primary and cispl...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-09-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.1682 |